89
Participants
Start Date
February 28, 2009
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
lanreotide (Autogel formulation)
Autogel 120 mg
Hôpital R. Debré, Reims
CAC Oscar Lambret, Lille
Hôpital Edouard Herriot, Lyon
Cedars-Sinai Outpatient Cancer Center, Los Angeles
Hôpital Beaujon, Clichy
The Johns Hopkins Hospital, Baltimore
UZ Antwerpen, Antwerp
UCL Saint Luc, Brussels
Fakultni nemocnice Na Bulovce, Prague
General faculty, Prague
Centro di Refierimiento Oncologica, Aviano
INSCT, Milan
University of Naples, Naples
Azienda San Giovanni Battista, Torino
"Centrum Diagnostyczno-Lecznicze Gammed", Warsaw
Zaklad Diagnosttyki Radiologicznej, Centralny Szpital Klincny, Warsaw
Narodny onkologicky ustav, Bratislava
Hospital Vall d'Hebron, Barcelona
Institut Catala Oncologia, Barcelona
University Hospital Wales, Cardiff
Western General Hospital, Edinburgh
Beatson West of Scotland Cancer Centre, Glasgow
St James Hospital, Leeds
Royal Free Hospital, London
QMC, Nottingham
Lead Sponsor
Ipsen
INDUSTRY